See also: New Drug Approvals for 2002
Rytelo (imetelstat) is an oligonucleotide telomerase inhibitor indicated for...
mRESVIA is a modified RNA vaccine that may protect adults aged 60 years and...
Bkemv (eculizumab-aeeb) is a complement inhibitor interchangeable biosimilar to...
More drug approvals